RxSight
RXST
RXST
228 hedge funds and large institutions have $1.98B invested in RxSight in 2024 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 75 increasing their positions, 79 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
228
Holders Change
+31
Holders Change %
+15.74%
% of All Funds
3.32%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.1%
New
52
Increased
75
Reduced
79
Closed
19
Calls
$4.25M
Puts
$752K
Net Calls
+$3.5M
Net Calls Change
-$1.4M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
$121M |
| 2 |
Marshall Wace
London,
United Kingdom
|
$19.5M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
$42.5M |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
$21.6M |
| 5 |
BlackRock
New York
|
$144M |
Top Sellers
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
$11.4M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
$80.3M |
| 3 |
Nuveen Asset Management
Chicago,
Illinois
|
$33.6M |
| 4 |
Millennium Management
New York
|
$11.3M |
| 5 |
JPMorgan Chase & Co
New York
|
$11.1M |
